The drive-line to power contemporary ventricular assist devices exiting the skin is associated with infection, and requires a holstered performance of the cardiac pump, which reduces overall quality of life. Attempts to eliminate the drive-line using transcutaneous energy transfer systems have been explored but have not succeeded in viable widespread application. The unique engineering of the coplanar energy transfer system is characterized by 2 large rings utilizing a coil-within-the-coil topology, ensuring robust resonance energy transfer while allowing for a substantial (>6 hours) unholstered circulatory support powered by an implantable battery source. Herein we report the first known human experience with this novel technology, coupled with a continuous-flow assist left ventricular assist device, in 2 consecutive patients evaluated with the primary end-point of system performance at 30 days post-implantation.
Pya, Y., Maly, J., Bekbossynova, M., Salov, R., Schueler, S., Meyns, B., Kassif, Y., Massetti, M., Zilbershlag, M., Netuka, I., First human use of a wireless coplanar energy transfer coupled with a continuous-flow left ventricular assist device, <<THE JOURNAL OF HEART AND LUNG TRANSPLANTATION>>, 2019; 38 (4): 339-343. [doi:10.1016/j.healun.2019.01.1316] [http://hdl.handle.net/10807/146184]
First human use of a wireless coplanar energy transfer coupled with a continuous-flow left ventricular assist device
Massetti, Massimo;
2019
Abstract
The drive-line to power contemporary ventricular assist devices exiting the skin is associated with infection, and requires a holstered performance of the cardiac pump, which reduces overall quality of life. Attempts to eliminate the drive-line using transcutaneous energy transfer systems have been explored but have not succeeded in viable widespread application. The unique engineering of the coplanar energy transfer system is characterized by 2 large rings utilizing a coil-within-the-coil topology, ensuring robust resonance energy transfer while allowing for a substantial (>6 hours) unholstered circulatory support powered by an implantable battery source. Herein we report the first known human experience with this novel technology, coupled with a continuous-flow assist left ventricular assist device, in 2 consecutive patients evaluated with the primary end-point of system performance at 30 days post-implantation.File | Dimensione | Formato | |
---|---|---|---|
146184OA.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
1.17 MB
Formato
Unknown
|
1.17 MB | Unknown | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.